Title:
Ｅ型肝炎ウイルス様粒子を用いた多抗原送達系
Document Type and Number:
Japanese Patent JP5869885
Kind Code:
B2
Abstract:
This invention provides a peptide / nucleic acid composition for oral/mucosal, dual-modal activation of immune protection systems.
Inventors:
Chen, Earl., Holland
Shin, Li
Miyamura, Tatsuo
Yasumi, Yasuhiro
Li, Tian-Chen
Takeda, Naokazu
Shin, Li
Miyamura, Tatsuo
Yasumi, Yasuhiro
Li, Tian-Chen
Takeda, Naokazu
Application Number:
JP2011552226A
Publication Date:
February 24, 2016
Filing Date:
March 01, 2010
Export Citation:
Assignee:
The Regents of The University of California
Director, National Institute of Infectious Diseases
National Research and Development Agency Pharmaceutical Infrastructure, Health and Nutrition Institute
Director, National Institute of Infectious Diseases
National Research and Development Agency Pharmaceutical Infrastructure, Health and Nutrition Institute
International Classes:
C12N15/09; A61K31/7088; A61K38/00; A61K39/00; A61P31/04; A61P31/12; C07K14/08; C07K19/00; C12N7/04
Other References:
Acta Cryst., 2008年, F64, p.318-322
Virology, 2002年, 第293巻, p.273-280
臨床とウイルス, 2004年, 第32巻, p.362-371
Gene Ther., 2004年, 第11巻, p.628-635
臨床免疫, 2005年, 第43巻, p.635-639
Virology, 2002年, 第293巻, p.273-280
臨床とウイルス, 2004年, 第32巻, p.362-371
Gene Ther., 2004年, 第11巻, p.628-635
臨床免疫, 2005年, 第43巻, p.635-639
Attorney, Agent or Firm:
Atsushi Nakajima
Kato Kazunori
Kato Kazunori
Previous Patent: 細胞周期の不定期の活性化に関連する神経変性障害または疾患の治療に有...
Next Patent: NEW PHYSIOLOGICALLY ACTIVE SUBSTANCE LACRIMIN
Next Patent: NEW PHYSIOLOGICALLY ACTIVE SUBSTANCE LACRIMIN